2024년에 79억 달러로 추정되는 세계의 커넥티드 약물전달 기기 시장은 2024-2030년에 CAGR 21.5%로 성장하며, 2030년에는 255억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 스탠드얼론 컴포넌트 & 소프트웨어는 CAGR 20.2%를 기록하며, 분석 기간 종료시에는 148억 달러에 달할 것으로 예측됩니다. 집적 디바이스 분야의 성장률은 분석 기간 중 CAGR 23.4%로 추정됩니다.
미국 시장은 21억 달러, 중국은 CAGR 20.4%로 성장 예측
미국의 커넥티드 약물전달 기기 시장은 2024년에 21억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 39억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 20.4%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 19.3%와 18.4%로 예측됩니다. 유럽에서는 독일이 CAGR 약 14.7%로 성장할 것으로 예측됩니다.
세계의 커넥티드 약물전달 기기 시장 - 주요 동향과 촉진요인 정리
커넥티드 약물전달 기기란 무엇이며, 왜 헬스케어에 변화를 초래하는가?
커넥티드 약물전달 기기는 약물 투여를 모니터링하고 관리할 수 있는 센서와 연결 기능을 갖춘 의료기기입니다. 스마트 흡입기, 인슐린 펜, 웨어러블 주사기, 자동 주사기 등이 포함되며, 실시간으로 사용 데이터를 의료진에게 전송하여 환자의 복약 순응도 및 치료 효과에 대한 인사이트를 제공합니다. 커넥티드 약물전달 기기는 복약 순응도를 향상시키고, 개인 맞춤형 투약 지침을 제공하며, 환자의 원격 모니터링을 가능하게 합니다. 이러한 기기들은 환자와 의료진 간의 원활한 소통을 촉진함으로써 의료 서비스 제공에 변화를 가져오고, 환자가 가장 효과적이고 개인화된 치료를 받을 수 있도록 돕습니다.
커넥티드 약물전달 기기의 중요성은 당뇨병, 천식, 류마티스 관절염과 같은 만성질환의 관리에 필수적인 환자 참여와 처방된 요법의 순응도를 높이는 능력에 있습니다. 이러한 기기를 통해 수집된 데이터는 의료진에게 치료 패턴과 환자 행동에 대한 실질적인 인사이트를 제공하고, 순응도 문제가 발생했을 때 적극적인 개입을 가능하게 합니다. 또한 커넥티드 디바이스가 제공하는 실시간 피드백은 환자의 복약 관리를 보다 효과적으로 돕고, 복약 누락 및 합병증 발생 위험을 줄일 수 있습니다. 헬스케어 시스템이 점점 더 환자 중심의 데이터베이스 치료에 초점을 맞추고 있는 가운데, 커넥티드 약물전달 기기는 치료 결과를 개선하는 데 중요한 역할을 하고 있습니다.
기술의 발전은 어떻게 연결형 약물전달 장비를 개선하고 있는가?
기술의 발전으로 커넥티드 약물전달 기기의 기능과 용도이 빠르게 향상되어 더욱 정확하고, 환자 친화적이며, 다용도해지고 있으며, 블루투스, 와이파이, 근거리무선통신(NFC) 기술의 통합으로 기기에서 모바일 앱과 클라우드 플랫폼으로 데이터를 원활하게 전송할 수 있게 되었습니다. AI와 머신러닝 알고리즘은 커넥티드 약물전달 기기를 혁신적으로 변화시켜 개인화된 투약 스케줄을 가능하게 하고, 환자 행동에 기반한 adherence pattern을 분석할 수 있는 개인화된 투약 스케줄을 가능하게 합니다. 환자의 행동에 따라 순응도 패턴을 예측하여 전반적인 치료 효과를 향상시키고 있습니다.
웨어러블 기술의 발달로 스마트 인슐린 펌프, 웨어러블 주사기 등 보다 편안하고 눈에 잘 띄지 않는 디바이스가 개발되어 일상 생활에 지장을 최소화하면서 투약할 수 있게 되었습니다. 또한 모바일 앱과의 통합을 통해 환자는 알림, 복용량 추적, 교육 리소스를 받을 수 있으며, 복약 순응도를 높이고 환자가 자신의 상태를 능동적으로 관리할 수 있도록 돕습니다. 배터리 수명이 길어지고 크기가 작아짐에 따라 이러한 장비는 휴대가 간편하고 사용하기 쉬워져 활동적이고 이동이 많은 환자들의 요구를 충족시킬 수 있게 되었습니다. 이러한 기술적 진보로 인해 커넥티드 약물전달 기기는 현대 의료에 필수적인 존재가 되어 환자의 순응도, 편의성 및 치료 성공률을 향상시키고 있습니다.
환자 치료에서 커넥티드 약물전달 기기의 주요 용도는 무엇인가?
커넥티드 약물전달 기기는 일관된 복약 순응도가 필수적인 만성질환 관리 용도에 광범위하게 사용되고 있습니다. 당뇨병 관리의 경우, 스마트 인슐린 펜과 지속형 혈당 측정기(CGM)는 환자가 인슐린 용량을 정확하게 관리하고 추적할 수 있도록 도와주며, 개인별 맞춤 투여를 지원하는 데이터를 제공하여 합병증 위험을 줄일 수 있습니다. 천식이나 만성폐쇄성폐질환(COPD)과 같은 호흡기 질환의 경우, 연결된 흡입기는 흡입기 사용에 대한 알림과 피드백을 제공하여 환자가 처방된 요법을 준수할 수 있도록 돕고, 의료진이 원격으로 환자의 상태를 모니터링할 수 있도록 합니다.
종양학 분야에서는 웨어러블 주사기를 통해 화학요법 약물전달을 제어할 수 있으며, 잦은 병원 방문의 필요성을 줄이고 환자가 집에서 치료를 관리할 수 있도록 돕습니다. 류마티스 관절염 치료에서 커넥티드 자동 주사기는 환자가 처방된 대로 약물을 투여받을 수 있도록 하고, 의료진이 치료 계획을 최적화하는 데 사용할 수 있는 데이터를 제공합니다. 임상시험에서 커넥티드 약물전달 기기는 정확한 투약 정보를 획득하여 데이터의 정확성을 향상시키고, 환자의 자기보고에 대한 의존도를 낮추며, 시험의 무결성을 향상시킵니다. 이러한 용도는 커넥티드 약물전달 기기가 질병 관리에서 임상 연구에 이르기까지 환자 치료의 다양한 측면을 지원하는 다용도성을 강조하고 있습니다.
커넥티드 약물전달 기기 시장의 성장을 가속하는 요인은 무엇인가?
커넥티드 약물전달 기기 시장의 성장은 만성질환 증가, 커넥티드 헬스케어의 기술 발전, 환자의 순응도 향상에 대한 관심 증가 등 여러 요인에 기인합니다. 당뇨병, 천식, 심혈관 질환과 같은 만성질환의 유병률이 증가함에 따라 커넥티드 약물전달 기기는 순응도를 높이고 효과적인 치료 결과를 보장하는 역할을 하므로 높은 수요가 있으며, AI, 모바일 앱 통합, 실시간 데이터 분석과 같은 기술 발전으로 인해 이러한 기기의 기능이 강화되고 있습니다. 이러한 장비의 기능이 향상되어 사용하기 쉽고 원격으로 환자 치료를 관리할 수 있게 되었습니다.
원격의료 및 원격 환자 모니터링에 대한 수용이 확대됨에 따라 의료 서비스 프로바이더는 복약 순응도를 추적하고 필요한 경우 개입할 수 있으며, 병원 방문 횟수를 줄이고 환자 참여도를 높일 수 있습니다. 또한 맞춤형 의료에 대한 관심이 높아지면서 맞춤형 투약 스케줄과 실시간 모니터링을 제공하는 기기에 대한 수요도 증가하고 있으며, 이는 맞춤형 치료 솔루션을 찾는 추세에 부합합니다. 또한 제약회사와 의료 서비스 프로바이더들은 임상시험에서 커넥티드 약물전달 기기의 이점을 인식하고 있으며, 커넥티드 약물전달 기기는 데이터의 정확성과 환자의 순응도를 향상시킵니다. 이러한 요인들이 복합적으로 작용하여 커넥티드 약물전달 기기 시장의 성장을 가속하고, 디지털화되는 의료 환경에서 의료 서비스 제공과 환자 결과를 개선하는 데 중요한 역할을 하고 있습니다.
부문
제공(스탠드얼론 컴포넌트 & 소프트웨어, 통합 디바이스); 투여 경로(비경구투여, 흡입 투여); 애플리케이션(당뇨병 관리 애플리케이션, COPD 애플리케이션, 천식 애플리케이션, 기타 애플리케이션)
조사 대상 기업의 예
Adherium Limited
Aterica
Biocorp
FindAir
Merck KGaA
Phillips Medisize
Propeller Health
Proteus Digital Health
West Pharmaceutical Services, Inc.
AI 통합
Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.
Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.
목차
제1장 조사 방법
제2장 개요
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
KSA
영문 목차
영문목차
Global Connected Drug Delivery Devices Market to Reach US$25.5 Billion by 2030
The global market for Connected Drug Delivery Devices estimated at US$7.9 Billion in the year 2024, is expected to reach US$25.5 Billion by 2030, growing at a CAGR of 21.5% over the analysis period 2024-2030. Standalone Components & Software, one of the segments analyzed in the report, is expected to record a 20.2% CAGR and reach US$14.8 Billion by the end of the analysis period. Growth in the Integrated Devices segment is estimated at 23.4% CAGR over the analysis period.
The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 20.4% CAGR
The Connected Drug Delivery Devices market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2030 trailing a CAGR of 20.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 19.3% and 18.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.7% CAGR.
Global Connected Drug Delivery Devices Market - Key Trends & Drivers Summarized
What Are Connected Drug Delivery Devices, and Why Are They Transforming Healthcare?
Connected drug delivery devices are medical devices equipped with sensors and connectivity features that allow for the monitoring and management of drug administration. These devices include smart inhalers, insulin pens, wearable injectors, and auto-injectors that transmit real-time usage data to healthcare providers, offering insights into patient adherence and treatment efficacy. Connected drug delivery devices improve medication compliance, provide personalized dosage guidance, and enable remote patient monitoring, making them especially valuable in chronic disease management, where adherence to treatment is crucial for health outcomes. By facilitating seamless communication between patients and healthcare providers, these devices are transforming healthcare delivery, ensuring that patients receive the most effective, personalized care.
The significance of connected drug delivery devices lies in their ability to enhance patient engagement and adherence to prescribed regimens, which is vital in managing chronic conditions like diabetes, asthma, and rheumatoid arthritis. The data collected by these devices offers healthcare providers actionable insights into treatment patterns and patient behavior, enabling proactive intervention when adherence issues arise. Additionally, the real-time feedback provided by connected devices helps patients manage their medications more effectively, reducing the risk of missed doses and potential complications. As healthcare systems increasingly focus on patient-centered, data-driven care, connected drug delivery devices play a crucial role in improving treatment outcomes.
How Are Technological Advancements Enhancing Connected Drug Delivery Devices?
Technological advancements are rapidly improving the capabilities and applications of connected drug delivery devices, making them more precise, patient-friendly, and versatile. Integration of Bluetooth, Wi-Fi, and near-field communication (NFC) technologies allows for seamless data transfer from the device to mobile apps and cloud platforms, where data can be analyzed and accessed by healthcare providers in real time. AI and machine learning algorithms are also transforming connected drug delivery devices, enabling personalized medication schedules and predicting adherence patterns based on patient behavior, enhancing the overall treatment efficacy.
Advances in wearable technology have led to the development of more comfortable and discreet devices, such as smart insulin pumps and wearable injectors, that can deliver medication with minimal disruption to daily life. Furthermore, mobile app integration allows patients to receive reminders, dosage tracking, and educational resources, which promotes adherence and empowers patients to manage their conditions actively. Enhanced battery life and miniaturization have made these devices more portable and user-friendly, catering to the needs of active and mobile patients. Together, these technological advancements make connected drug delivery devices an integral part of modern healthcare, improving patient adherence, convenience, and treatment success.
What Are the Key Applications of Connected Drug Delivery Devices Across Patient Care?
Connected drug delivery devices are widely used across a range of chronic disease management applications, where consistent medication adherence is essential. In diabetes management, smart insulin pens and continuous glucose monitors (CGMs) allow patients to administer and track insulin doses accurately, providing data that supports personalized dosing and reduces the risk of complications. For respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), connected inhalers offer reminders and feedback on inhaler usage, helping patients adhere to prescribed regimens and enabling providers to monitor control of the condition remotely.
In the field of oncology, wearable injectors allow for controlled delivery of chemotherapy drugs, reducing the need for frequent hospital visits and enabling patients to manage their treatment at home. Connected auto-injectors are used in rheumatoid arthritis treatment, ensuring patients receive their medications as prescribed and providing data that healthcare providers can use to optimize treatment plans. In clinical trials, connected drug delivery devices improve data accuracy by capturing precise dosing information, reducing reliance on patient self-reporting and enhancing trial integrity. These applications underscore the versatility of connected drug delivery devices in supporting various aspects of patient care, from disease management to clinical research.
What Factors Are Driving Growth in the Connected Drug Delivery Devices Market?
The growth in the connected drug delivery devices market is driven by several factors, including the rise of chronic diseases, technological advancements in connected healthcare, and increasing emphasis on patient adherence. With the prevalence of chronic conditions like diabetes, asthma, and cardiovascular disease on the rise, connected drug delivery devices are in high demand for their role in improving adherence and ensuring effective treatment outcomes. Technological advancements, such as AI, mobile app integration, and real-time data analytics, are enhancing the capabilities of these devices, making them more user-friendly and effective in managing patient care remotely.
The growing acceptance of telemedicine and remote patient monitoring has further boosted adoption, as connected drug delivery devices allow healthcare providers to track adherence and intervene when necessary, reducing hospital visits and improving patient engagement. Increased focus on personalized medicine has also spurred demand for devices that offer customizable dosing schedules and real-time monitoring, aligning with the trend toward tailored treatment solutions. Moreover, pharmaceutical companies and healthcare providers are recognizing the benefits of connected drug delivery devices in clinical trials, where they improve data accuracy and patient compliance. Together, these factors are driving the expansion of the connected drug delivery devices market, supporting its role in enhancing healthcare delivery and patient outcomes in an increasingly digital healthcare landscape.
SCOPE OF STUDY:
The report analyzes the Connected Drug Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 42 Featured) -
Adherium Limited
Aterica
Biocorp
FindAir
Merck KGaA
Phillips Medisize
Propeller Health
Proteus Digital Health
West Pharmaceutical Services, Inc.
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Global Economic Update
Connected Drug Delivery Devices - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Prevalence of Chronic Diseases Drives Demand for Connected Drug Delivery Devices That Enable Remote Patient Monitoring
Growth in Home Healthcare Expands Market for Connected Drug Delivery Devices That Offer Self-Administration and Real-Time Feedback
Rising Focus on Personalized Medicine Propels Demand for Connected Devices That Provide Customizable Dosing and Monitoring
Advancements in IoT Technology Strengthen Business Case for Connected Drug Delivery Devices with Real-Time Data Sharing
Growing Demand for Patient Adherence Solutions Drives Adoption of Connected Drug Delivery Devices with Reminder and Tracking Features
Expansion of Digital Health Solutions Supports Market for Connected Devices That Integrate with Mobile Apps and Health Portals
Increasing Focus on Reducing Healthcare Costs Drives Demand for Connected Drug Delivery Devices That Minimize Hospital Visits
Rising Use of AI in Healthcare Expands Market for Connected Devices with Predictive Analytics and Personalized Care Features
Increasing Need for Continuous Glucose Monitoring Expands Market for Connected Drug Delivery Devices in Diabetes Management
Growing Focus on Remote Clinical Trials Drives Demand for Connected Drug Delivery Devices That Enable Real-Time Data Collection
Rising Investment in Smart Inhalers and Connected Injectors Propels Growth in Asthma and Respiratory Disease Management
Increasing Adoption of Wearable Health Tech Expands Applications of Connected Drug Delivery Devices in Chronic Disease Management
Growth in Preventive Healthcare Expands Market for Connected Devices That Monitor Patient Metrics and Predict Health Risks
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Standalone Components & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 2: World 6-Year Perspective for Standalone Components & Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 3: World Recent Past, Current & Future Analysis for Integrated Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 4: World 6-Year Perspective for Integrated Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World 6-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Inhalational Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 8: World 6-Year Perspective for Inhalational Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 9: World Recent Past, Current & Future Analysis for Diabetes Management Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 10: World 6-Year Perspective for Diabetes Management Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for COPD Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World 6-Year Perspective for COPD Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Asthma Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 14: World 6-Year Perspective for Asthma Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 15: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 16: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 17: World Connected Drug Delivery Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 18: World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 19: World 6-Year Perspective for Connected Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 20: USA Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 21: USA 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
TABLE 22: USA Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 23: USA 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
TABLE 24: USA Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 25: USA 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
CANADA
TABLE 26: Canada Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 27: Canada 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
TABLE 28: Canada Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 29: Canada 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
TABLE 30: Canada Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 31: Canada 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
JAPAN
Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 32: Japan Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 33: Japan 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
TABLE 34: Japan Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 35: Japan 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
TABLE 36: Japan Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 37: Japan 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
CHINA
Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 38: China Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: China 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
TABLE 40: China Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 41: China 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
TABLE 42: China Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 43: China 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
EUROPE
Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 44: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: Europe 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
TABLE 46: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 47: Europe 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
TABLE 48: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 49: Europe 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 51: Europe 6-Year Perspective for Connected Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
FRANCE
Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 52: France Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 53: France 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
TABLE 54: France Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 55: France 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
TABLE 56: France Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: France 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
GERMANY
Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 58: Germany Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 59: Germany 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
TABLE 60: Germany Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 61: Germany 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
TABLE 62: Germany Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Germany 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
ITALY
TABLE 64: Italy Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 65: Italy 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
TABLE 66: Italy Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 67: Italy 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
TABLE 68: Italy Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: Italy 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
UNITED KINGDOM
Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 70: UK Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 71: UK 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
TABLE 72: UK Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 73: UK 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
TABLE 74: UK Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: UK 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
REST OF EUROPE
TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 77: Rest of Europe 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 79: Rest of Europe 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: Rest of Europe 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
ASIA-PACIFIC
Connected Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 83: Asia-Pacific 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 85: Asia-Pacific 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Asia-Pacific 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
REST OF WORLD
TABLE 88: Rest of World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Offering - Standalone Components & Software and Integrated Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 89: Rest of World 6-Year Perspective for Connected Drug Delivery Devices by Offering - Percentage Breakdown of Value Sales for Standalone Components & Software and Integrated Devices for the Years 2025 & 2030
TABLE 90: Rest of World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Administration Route - Parenteral Administration and Inhalational Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 91: Rest of World 6-Year Perspective for Connected Drug Delivery Devices by Administration Route - Percentage Breakdown of Value Sales for Parenteral Administration and Inhalational Administration for the Years 2025 & 2030
TABLE 92: Rest of World Recent Past, Current & Future Analysis for Connected Drug Delivery Devices by Application - Diabetes Management Application, COPD Application, Asthma Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Rest of World 6-Year Perspective for Connected Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Diabetes Management Application, COPD Application, Asthma Application and Other Applications for the Years 2025 & 2030
